Related Experiment Videos
Prospective study on captopril renography in hypertensive patients
D Roccatello1, G Picciotto, C Rabbia
1Istituto di Nefrourologia, Università di Torino, Italia.
American Journal of Nephrology
|January 1, 1992
Summary
Captopril-enhanced scintigraphy is a highly accurate method for detecting renovascular hypertension in hypertensive patients. This nuclear medicine technique demonstrated high sensitivity and specificity in identifying renal artery stenosis.
Area of Science:
- Nuclear Medicine
- Radiology
- Nephrology
Background:
- Renovascular hypertension is a significant cause of secondary hypertension.
- Accurate diagnosis is crucial for timely intervention and management.
- Captopril-enhanced scintigraphy offers a non-invasive approach to assess renal perfusion.
Purpose of the Study:
- To evaluate the diagnostic performance of captopril-enhanced scintigraphy in identifying renovascular hypertension.
- To determine the sensitivity, specificity, and accuracy of this imaging technique.
Main Methods:
- Analysis of 667 hypertensive patients using captopril-enhanced scintigraphy with 99mTc-DTPA, 123I-OIH, or 99mTc-MAG3.
- Comparison with nifedipine studies to assess reversibility of renogram parameters.
- Correlation of scintigraphic findings with arteriography in a subset of patients.
Main Results:
- Captopril-enhanced scintigraphy identified 8.7% of patients with abnormal findings suggestive of renovascular hypertension.
- Arteriography confirmed significant renal vascular stenosis (>50%) in 94.2% of patients with positive scintigraphy.
- The overall sensitivity was 91.6%, specificity 93.5%, and accuracy 92.5%.
Conclusions:
- Captopril-enhanced scintigraphy is a sensitive and specific tool for diagnosing renovascular hypertension.
- The technique demonstrates high accuracy in detecting renal artery stenosis.
- It is a valuable non-invasive method for hypertensive patients requiring evaluation for renovascular disease.